Thymosin α1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: Preliminary results
- 31 December 1994
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 16 (12) , 1019-1025
- https://doi.org/10.1016/0192-0561(94)90081-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prothymosin α restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancerInternational Journal of Cancer, 1993
- Antitumor Effect of Thymosin α1/Interleukin-2 or Thymosin α1/Interferon α,β Following Cyclophosphamide in Mice Injected with Highly Metastatic Friend Erythroleukemia CellsJournal of Immunotherapy, 1993
- “Nk-Like” T Cytotoxicity Against B Lymphocytes in a Hypogammaglobulinemic PatientImmunological Investigations, 1992
- Decreased natural killer cell activity in late-onset hypogammaglobulinaemiaClinical Science, 1990
- Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytesInternational Journal of Immunopharmacology, 1990
- Lymphokine-activated killer cells in primary immunodeficiencies and acquired immunodeficiency syndromeClinical Immunology and Immunopathology, 1989
- Reconstitution of T cell functions in aging mice by thymosin α1Immunopharmacology, 1986
- PROSPECTIVE STUDY OF CANCER IN PATIENTS WITH HYPOGAMMAGLOBULINAEMIAThe Lancet, 1985
- Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.Journal of Clinical Investigation, 1982
- Immunodeficiency in humans as a risk factor in the development of malignancyPreventive Medicine, 1980